Oncor Electric Delivery Company LLC

08/30/2024 | Press release | Distributed by Public on 08/30/2024 14:18

Financial Obligation Form 8 K

ITEM 2.03

CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCESHEET ARRANGEMENT OF A REGISTRANT.

As previously reported, in April 2023, Oncor Electric Delivery Company LLC ("Oncor") entered into a revolving accounts receivable securitization facility (the "AR Facility") with MUFG Bank, Ltd., as administrative agent ("MUFG"). In connection with the AR Facility, Oncor contributes all of its existing, and has committed to continue to contribute or sell all of its future, accounts receivable from retail electric providers and certain related rights to Receivables LLC (as defined below) pursuant to the terms of the Purchase and Sale Agreement, dated as of April 28, 2023 (the "Sale Agreement"), among Oncor, any additional originators from time to time party thereto and Oncor Receivables LLC, a bankruptcy-remote special purpose entity and wholly-owned subsidiary of Oncor ("Receivables LLC"). Pursuant to the Receivables Financing Agreement, dated as of April 28, 2023 (as amended, the "Receivables Financing Agreement"), among Oncor, Receivables LLC, MUFG and certain lenders and group agents from time to time party thereto, Receivables LLC will obtain loans from the lenders secured by all of Receivables LLC's assets, including the receivables and related rights that it owns. The aggregate amount available for borrowing at any one time under the AR Facility is limited to the lesser of the facility limit of $500 million and the borrowing base amount calculated based on the outstanding balance of eligible receivables held as collateral, subject to certain reserves, concentration limits, and other limitations.

On August 30, 2024, $235 million aggregate principal amount was borrowed under the AR Facility. The proceeds from this borrowing are intended to be used for general corporate purposes, including repayment of outstanding commercial paper notes issued under Oncor's commercial paper program. Following this borrowing, $375 million aggregate principal amount is currently outstanding under the AR Facility. The AR Facility will terminate at the earlier of (i) the scheduled termination date of April 28, 2027, (ii) the date on which the termination date is declared or deemed to have occurred upon the exercise of remedies by MUFG as set forth in the Receivables Financing Agreement, or (iii) the date that is 30 days after notice of termination is provided by Receivables LLC. Subject to the consent of MUFG and the lenders, Receivables LLC may, 30 days prior to each anniversary date of the Receivables Financing Agreement, extend the AR Facility in one-year increments.

Borrowings under the AR Facility bear interest at (i) the daily cost of asset-backed commercial paper issued by the conduit lenders to fund the loans, plus related dealer commissions and note issuance costs or (ii) if funded by the committed lenders, at a rate per annum equal to the secured overnight financing rate ("SOFR") calculated based on term SOFR for a one-month interest period, plus 0.10%.Receivables LLC also pays a used and unused fee in connection with the AR Facility.

Receivables LLC's sole business consists of the purchase or acceptance through capital contributions of the receivables and related rights from Oncor and the subsequent retransfer of or granting of a security interest in such receivables and related rights to MUFG as administrative agent for the benefit of the lenders pursuant to the Receivables Financing Agreement. Receivables LLC is a separate legal entity with its own separate creditors who will be entitled, upon its liquidation, to have amounts owed to them be satisfied out of Receivables LLC's assets prior to any assets or value in Receivables LLC becoming available to Receivables LLC's equity holder. The assets of Receivables LLC are not available to pay creditors of Oncor or any affiliate thereof.

Additional details regarding the AR Facility, the Receivables Financing Agreement and the Sale Agreement are contained in Item 1.01 and Item 2.03 of Oncor's Current Report on Form 8-K filed with theSecurities and Exchange Commission (the "SEC") on April 28, 2023 and Item 1.01 of Oncor's Current Report on Form 8-Kfiled with the SEC on April 30, 2024 (collectively, the "Prior 8-Ks") and are incorporatedherein by reference. The foregoing discussion of the terms of the AR Facility, the Receivables Financing Agreement and the Sale Agreement are not complete and are subject to, and qualified in their entirety by reference to, the Receivables Financing Agreement and Sale Agreement filed as exhibits to the Prior 8-Ks.